Partial hepatectomy (PHx) is the gold standard for the treatment of colorectal cancer liver metastases. However, after removing a substantial amount of hepatic tissue, growth factors are released to induce liver regeneration, which may promote the proliferation of liver micrometastases or circulating tumour cells still present in the patient. The aim of this study is to assess the effect of PHx on the growth of liver metastases induced by intrasplenic cell inoculation as well as on in vitro proliferation of the same cancer cell line. Liver tumours were induced in 18 WAG/RijHsd male rats, by seeding 250,000 syngeneic colorectal cancer cells (CC531) into the spleen. The left lateral lobe of the liver was mobilized and in half of the animals i...
Characterization of transcriptional changes after partial hepatectomy (PH) may provide an understand...
Metastatic colorectal cancer (mCRC) is a devastating disease causing 700.000 deaths annually worldwi...
Resection is the only curative treatment for liver metastasis of colorectal cancers. Despite the sup...
Residual tumor in the remnant liver after partial hepatectomy (PH) for colorectal liver metastases i...
Background: Surgical resection remains the most effective therapy for metastatic colorectal cancer c...
This study investigated whether partial hepatectomy enhances the growth of experimental liver metast...
Colorectal cancer is the third commonest cancer in men, and the second commonest in women. The liver...
Tumour-bearing rats were randomized to a 70% partial hepatectomy or a sham operation. At days 1, 3 o...
OBJECTIVE: To validate proliferating cell nuclear antigen (PCNA) expression and flow cytometry as pr...
BACKGROUND Associating liver partition and portal vein ligation for staged hepatectomy induces an u...
BACKGROUND: The mechanisms and kinetics of hepatic growth have continuously been investigated. This...
Recent clinical data support an aggressive surgical approach to both primary and metastatic liver tu...
AbstractBackgroundChemotherapy before resection of colorectal metastases in the liver is extensively...
AbstractBackgroundPatients with hilar cholangiocarcinoma or hepatolithiasis often develop segmental ...
Background: Partial hepatectomy is the strongest stimulator of hepatic regeneration. The process of ...
Characterization of transcriptional changes after partial hepatectomy (PH) may provide an understand...
Metastatic colorectal cancer (mCRC) is a devastating disease causing 700.000 deaths annually worldwi...
Resection is the only curative treatment for liver metastasis of colorectal cancers. Despite the sup...
Residual tumor in the remnant liver after partial hepatectomy (PH) for colorectal liver metastases i...
Background: Surgical resection remains the most effective therapy for metastatic colorectal cancer c...
This study investigated whether partial hepatectomy enhances the growth of experimental liver metast...
Colorectal cancer is the third commonest cancer in men, and the second commonest in women. The liver...
Tumour-bearing rats were randomized to a 70% partial hepatectomy or a sham operation. At days 1, 3 o...
OBJECTIVE: To validate proliferating cell nuclear antigen (PCNA) expression and flow cytometry as pr...
BACKGROUND Associating liver partition and portal vein ligation for staged hepatectomy induces an u...
BACKGROUND: The mechanisms and kinetics of hepatic growth have continuously been investigated. This...
Recent clinical data support an aggressive surgical approach to both primary and metastatic liver tu...
AbstractBackgroundChemotherapy before resection of colorectal metastases in the liver is extensively...
AbstractBackgroundPatients with hilar cholangiocarcinoma or hepatolithiasis often develop segmental ...
Background: Partial hepatectomy is the strongest stimulator of hepatic regeneration. The process of ...
Characterization of transcriptional changes after partial hepatectomy (PH) may provide an understand...
Metastatic colorectal cancer (mCRC) is a devastating disease causing 700.000 deaths annually worldwi...
Resection is the only curative treatment for liver metastasis of colorectal cancers. Despite the sup...